Ownership

Elvia Cowan

Insider Reports History

Entity: Individual
Location: C/O Vaxcyte, Inc., 825 Industrial Road, Suite 300, San Carlos, CA
Signature: Elvia Cowan, by /s/ Peter N. Efremenko, Attorney-In-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elvia Cowan:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Vaxcyte, Inc.	SVP, FINANCE	Common Stock	24.1K	$1.74M	$72.10	Mar 3, 2025	Direct
Vaxcyte, Inc.	SVP, FINANCE	Stock Option (right to buy)	18K			Feb 27, 2025	Direct
Vaxcyte, Inc.	SVP, FINANCE	Performance Stock Option (right to buy)	11.9K			Nov 7, 2024	Direct

Showing 1 to 3 of 3 entries

Insider Reports Filed by Elvia Cowan

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
PCVX	Vaxcyte, Inc.	Feb 27, 2025	4	-$41.1K	4	Mar 3, 2025	SVP, FINANCE
PCVX	Vaxcyte, Inc.	Dec 16, 2024	2	$200K	4	Dec 18, 2024	SVP, FINANCE
PCVX	Vaxcyte, Inc.	Nov 7, 2024	1	$0	4	Nov 8, 2024	SVP, FINANCE
PCVX	Vaxcyte, Inc.	Sep 3, 2024	4	-$535K	4	Sep 5, 2024	SVP, FINANCE
PCVX	Vaxcyte, Inc.	Jul 16, 2024	3	-$295K	4	Jul 17, 2024	SVP, FINANCE
PCVX	Vaxcyte, Inc.	Jul 8, 2024	3	-$270K	4	Jul 9, 2024	SVP, FINANCE
PCVX	Vaxcyte, Inc.	Feb 29, 2024	8	-$603K	4	Mar 4, 2024	SVP, FINANCE
PCVX	Vaxcyte, Inc.	Sep 5, 2023	1	-$32K	4	Sep 6, 2023	SVP, Finance
PCVX	Vaxcyte, Inc.	Mar 1, 2023	2	$0	4	Mar 3, 2023	SVP, Finance
PCVX	Vaxcyte, Inc.	Jan 1, 2023	0	$0	3	Jan 4, 2023	SVP, Finance and Principal Accounting Officer